Rosacea News and Research

RSS
Rosacea is a common and chronic skin condition characterized by flushing, burning and stinging of the skin. The symptoms mainly appear on the face, often affecting the nose, cheeks and chin. Whilst it is not known exactly what causes rosacea, certain triggers have been identified. Common risk factors include sunlight exposure and hot weather, stress, certain foods and drinks, strenuous exercise and some medications.

Rosacea is estimated to affect up to 10% of people, with those aged between 30 and 50 being the most commonly affected. Whilst women tend to develop the condition more frequently than men, the symptoms of rosacea often present more severely in men.

Treatments for rosacea focus on managing the symptoms, as there is currently no cure for the condition. Identifying triggers and learning to avoid them play a large role in easing symptoms. Certain medicines, both topical and oral, may also be used to help control flare ups.
Galderma Laboratories' Differin Lotion receives FDA approval

Galderma Laboratories' Differin Lotion receives FDA approval

Proper diagnosis, treatment and good skin care help control acne and rosacea

Proper diagnosis, treatment and good skin care help control acne and rosacea

freshHAIR: A new hair care line to prevent acne

freshHAIR: A new hair care line to prevent acne

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

ZO Skin Health files complaint against Obagi Medical Products

ZO Skin Health files complaint against Obagi Medical Products

Revance Therapeutics closes $35 million Series D financing

Revance Therapeutics closes $35 million Series D financing

CDA launches Acne And Rosacea Awareness Campaigns

CDA launches Acne And Rosacea Awareness Campaigns

New study reveals certain prescription drugs can be harmful to fetus

New study reveals certain prescription drugs can be harmful to fetus

FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel

FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel

Tips for treating age-related dermatologic concerns

Tips for treating age-related dermatologic concerns

Oxygen Biotherapeutics announces its expanded product development plan

Oxygen Biotherapeutics announces its expanded product development plan

Premier Plastic Surgery redesigns its website to provide more information of cosmetic surgery

Premier Plastic Surgery redesigns its website to provide more information of cosmetic surgery

Multi-million dollar cooperative agreement for SMA drug development program

Multi-million dollar cooperative agreement for SMA drug development program

940nm wavelength laser is superior for treating facial spider veins: BUSM researchers

940nm wavelength laser is superior for treating facial spider veins: BUSM researchers

New consumer At-Home Skin Typing and Analysis Kit unveiled

New consumer At-Home Skin Typing and Analysis Kit unveiled

Impax Laboratories challenges Galderma Laboratories' patents

Impax Laboratories challenges Galderma Laboratories' patents

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Signum Biosciences awarded $1.6 million SBIR Phase II grant

Signum Biosciences awarded $1.6 million SBIR Phase II grant

Results of Phase 2 rheumatoid arthritis clinical trial announced

Results of Phase 2 rheumatoid arthritis clinical trial announced

Intendis GmbH forges agreement with SkinMedica to acquire two prescription dermatology products

Intendis GmbH forges agreement with SkinMedica to acquire two prescription dermatology products